Respond Systems, a trusted leader in animal health technology, is now Respond Animal Therapeutics, a name that more accurately reflects their comprehensive approach to animal health by offering ...

Repare Therapeutics Inc. (Repare), a leading clinical-stage precision oncology company, announced that it has out-licensed its discovery platforms, including certain platform and programme ...

Repare’s chemogenomic discovery platform leverages CRISPR-enabled technology. Credit: Prostock-studio/Shutterstock. Repare Therapeutics has entered an out-licensing ...

Repare Therapeutics Inc. ("Repare") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its discovery platforms, including certain ...

CAMBRIDGE, Mass. & MONTREAL, May 01, 2025--(BUSINESS WIRE)--Repare Therapeutics Inc. ("Repare") (Nasdaq: RPTX), a leading clinical-stage precision oncology company ...

CAMBRIDGE, Mass. & MONTREAL, May 01, 2025--(BUSINESS WIRE)--Repare Therapeutics Inc. ("Repare") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has ...

CAMBRIDGE, Mass. & MONTREAL — Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its discovery platforms, ...

Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash upfront through a subsidiary ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Repare Therapeutics Inc. before investing. In this article, we go over a few key ...